Project Grant RF1AG077610
Award Date
6/1/22
Completion Date
5/31/25
Dollars Obligated
$4.3M
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Florida, USA
Similar Awards
This three-year, $4.5 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, supports research under the Aging Research program (CFDA 93.866). The University of South Florida will investigate the role of the BIN1 gene in Alzheimer's disease pathogenesis and neuroinflammatory signaling by microglia. Researchers will generate mouse models lacking BIN1 specifically in microglia to study effects on amyloid plaque burden, tau pathology...
This Project Grant award, totaling $2,286,635, was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The award supports research to investigate the contribution of genetic risk factors and microglial dysfunction in the Bridging Integrator 1 (BIN1) gene to the development and progression of tauopathy, a hallmark pathology of Alzheimer's disease. The research, conducted by the University of California, San Diego, will employ...
This $466,531 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will support research by Texas A&M AgriLife Research to investigate the role of the BIN1 protein in oligodendrocytes and its impact on axon integrity. The research aims to provide new insights into how the BIN1 genetic risk factor may relate to the onset and progression of late-onset Alzheimer's disease. The project will utilize oligodendrocyte-specific BIN1 knockout mice and a...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) is providing $2,836,419 to the Seattle Institute for Biomedical and Clinical Research to investigate how the SUT-6/NIPP1 protein regulates pathological tau in Alzheimer's disease and other neurodegenerative "tauopathy" conditions. The key objectives are to: 1) define the functions of SUT-6/NIPP1 important for suppressing tau toxicity in a C. elegans model, 2) identify downstream...
This $1,823,353 Project Grant awarded by the National Institute on Aging (CFDA 93.866 Aging Research) to the Seattle Institute For Biomedical And Clinical Research aims to elucidate the molecular mechanisms by which pathological tau protein causes neurodegeneration in Alzheimer's disease (AD) and related tauopathy disorders. The research project will leverage a C. elegans model of tauopathy to investigate the functional role of nuclear speckles, membraneless organelles involved in RNA...
This Project Grant from the National Institute on Aging, part of the Department of Health and Human Services, provides $3,018,210 to Baylor College of Medicine under the Aging Research program (CFDA 93.866). The grant funds research to functionally dissect a promising transcriptional regulatory network linked to glutamate excitatory signaling that is downregulated in Alzheimer's disease and enriched for suppressors of neurodegeneration. Researchers will perform genetic manipulations in...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,100,000 to the University of Texas Medical Branch at Galveston to investigate the mechanisms of pathological tau protein spreading in Alzheimer's disease. The project aims to determine how amyloid-beta oligomers modulate the binding and internalization of toxic tau oligomers at vulnerable synapses, a key process underlying the spatiotemporal progression of tau pathology in the central nervous...
This $519,750 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a 2-year research study by the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco. The study aims to explore the underlying molecular mechanisms by which reducing levels of the tau protein can prevent or diminish excitation/inhibition imbalance and network hyperexcitability in the brain. This imbalance has been observed in various...
This $1,592,854 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research by the University of Illinois to understand the biological mechanisms underlying neurodegenerative tauopathy diseases, including Alzheimer's disease. The project aims to define how modifications to the tau protein, such as phosphorylation and other post-translational changes, can disrupt its normal scaffolding functions and lead to the dysregulation of critical...
This $1,003,116 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a research project led by the University of Alabama at Birmingham (UAB) to investigate mechanisms of synaptic resilience to tau pathology in Alzheimer's disease. The project aims to identify synaptic proteins and cellular pathways associated with modulating tau seeding, tau-induced synaptic dysfunction, and synapse preservation in Alzheimer's patients who exhibit cognitive...